Cellectar Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 110 | -49 | -52 | |
EBITDA | -5,763 | -5,245 | -4,391 | -5,392 |
EBIT | -5,653 | -5,295 | -4,443 | -5,447 |
Net Income | -5,653 | -5,295 | -4,443 | -5,447 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,848 | -4,350 | -4,275 | -5,115 |
Cash | 8,347 | 13,196 | 12,554 | 11,041 |
Basic Shares | 4,240 | 4,240 | 3,162 | 1,608 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -213 | -291 | -192 | -238 |
EBITDA | -21,577 | -44,223 | -42,638 | -28,665 |
EBIT | -21,791 | -44,515 | -42,830 | -28,813 |
Net Income | -21,791 | -44,581 | -42,770 | -28,601 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,124 | -47,687 | -33,241 | -25,448 |
Cash | 13,196 | 23,288 | 9,564 | 19,866 |
Basic Shares | 2,608 | 1,238 | 407 | 235 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.33 |
2025-12-31 | -$0.53 |
2025-09-30 | -$1.41 |
2025-06-30 | -$3.39 |